Needle-free Injection System Market - Development Endeavours & Business Opportunities

The needle-free injection system market is projected to reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0% from 2021 to 2026.

To know about the assumptions considered for the study download the pdf brochure @   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861

Growth in this market is mainly driven by technological advancements, increasing demand for self-injection devices, and the rising incidence of chronic diseases. With the rising geriatric population and the increasing prevalence of chronic diseases, the patient volume has increased significantly globally.

Global Needle-free Injection System Market Scope:

 PHARMAJET

PharmaJet held the first position in the needle-free injection system market in 2020. PharmaJet is a leading provider of needle-free injectors. The company has developed PharmaJet Needle-free devices that deliver pharmaceuticals, vaccines, and liquid injectables through the skin, accomplished by the use of jet injection technology. The company’s PharmaJet Needle-free Injector is easy-to-use and eliminates needlestick injuries, needle reuse, and cross-contamination.

PORTAL INSTRUMENTS

Portal Instruments is a Series-B funded medical device company focused on advanced drug delivery. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. The company’s strong focus on R&D and investments in collaborations, partnerships, and acquisitions have helped the company to secure a leading position in the market.

MEDICAL INTERNATIONAL TECHNOLOGY, INC (MIT)

MIT develops, manufactures, and markets needle-free jet injectors for veterinary and human applications through its subsidiary Medical International Technology (MIT Canada), Inc. The company has products for the human market and the animal market. MIT has domination in the market due to its expertise through R&D and has designed unique injection systems.

Click Here to Access a Free Sample Report of the Global Needle-free Injection System Market @  https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861

Recent Developments:

·         In December 2021, PharmaJet partner, Nykode Therapeutics announces phase 1/2 clinical trial with next-generation DNA-based COVID-19 vaccine candidates

·         In August 2021, PharmaJet partner Zydus Cadila announced Emergency Use Authorization approval for world’s first plasmid DNA COVID-19 vaccine deliver via needle-free injection.

·         In May 2021, Enesi pharma achieves key milestone in development of thermostable solid-dose live vaccines against Measles and Rubella and soon entering into clinical trials   

Our Free Sample Report Consists of the following:

·         Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.

·         The COVID-19 Pandemic Outbreak Impact Analysis is included in the package

·         About 220+ Pages Research Report (Including Recent Research)

·         Provide detailed chapter-by-chapter guidance on Request

·         Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022

·         Includes Tables and figures have been updated

·         The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis

Directly Purchase a copy of the report [238] @ https://www.marketsandmarkets.com/Purchase/purchase_reportNew.asp?id=165815861